van Rhijn BW - Search Results

1

Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment.

Pouessel D, Neuzillet Y, Mertens LS, van der Heijden MS, de Jong J, Sanders J, Peters D, Leroy K, Manceau A, Maille P, Soyeux P, Moktefi A, Semprez F, Vordos D, de la Taille A, Hurst CD, Tomlinson DC, Harnden P, Bostrom PJ, Mirtti T, Horenblas S, Loriot Y, Houédé N, Chevreau C, Beuzeboc P, Shariat SF, Sagalowsky AI, Ashfaq R, Burger M, Jewett MA, Zlotta AR, Broeks A, Bapat B, Knowles MA, Lotan Y, van der Kwast TH, Culine S, Allory Y, van Rhijn BW. Pouessel D, et al. Among authors: van rhijn bw, van der heijden ms, van der kwast th. Ann Oncol. 2016 Jul;27(7):1311-6. doi: 10.1093/annonc/mdw170. Epub 2016 Apr 18. Ann Oncol. 2016. PMID: 27091807 Free PMC article.

2

The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate.

van Rhijn BW, Lurkin I, Radvanyi F, Kirkels WJ, van der Kwast TH, Zwarthoff EC. van Rhijn BW, et al. Among authors: van der kwast th. Cancer Res. 2001 Feb 15;61(4):1265-8. Cancer Res. 2001. PMID: 11245416

3

Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors.

Billerey C, Chopin D, Aubriot-Lorton MH, Ricol D, Gil Diez de Medina S, Van Rhijn B, Bralet MP, Lefrere-Belda MA, Lahaye JB, Abbou CC, Bonaventure J, Zafrani ES, van der Kwast T, Thiery JP, Radvanyi F. Billerey C, et al. Am J Pathol. 2001 Jun;158(6):1955-9. doi: 10.1016/S0002-9440(10)64665-2. Am J Pathol. 2001. PMID: 11395371 Free PMC article.

4

Microsatellite analysis--DNA test in urine competes with cystoscopy in follow-up of superficial bladder carcinoma: a phase II trial.

van Rhijn BW, Lurkin I, Kirkels WJ, van der Kwast TH, Zwarthoff EC. van Rhijn BW, et al. Among authors: van der kwast th. Cancer. 2001 Aug 15;92(4):768-75. doi: 10.1002/1097-0142(20010815)92:4<768::aid-cncr1381>3.0.co;2-c. Cancer. 2001. PMID: 11550146

5

Frequent FGFR3 mutations in urothelial papilloma.

van Rhijn BW, Montironi R, Zwarthoff EC, Jöbsis AC, van der Kwast TH. van Rhijn BW, et al. Among authors: van der kwast th. J Pathol. 2002 Oct;198(2):245-51. doi: 10.1002/path.1202. J Pathol. 2002. PMID: 12237885

6

Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders.

van Rhijn BW, van Tilborg AA, Lurkin I, Bonaventure J, de Vries A, Thiery JP, van der Kwast TH, Zwarthoff EC, Radvanyi F. van Rhijn BW, et al. Among authors: van tilborg aa, van der kwast th. Eur J Hum Genet. 2002 Dec;10(12):819-24. doi: 10.1038/sj.ejhg.5200883. Eur J Hum Genet. 2002. PMID: 12461689

7

Combined microsatellite and FGFR3 mutation analysis enables a highly sensitive detection of urothelial cell carcinoma in voided urine.

van Rhijn BW, Lurkin I, Chopin DK, Kirkels WJ, Thiery JP, van der Kwast TH, Radvanyi F, Zwarthoff EC. van Rhijn BW, et al. Among authors: van der kwast th. Clin Cancer Res. 2003 Jan;9(1):257-63. Clin Cancer Res. 2003. PMID: 12538478

8

Surveillance with microsatellite analysis of urine in bladder cancer patients treated by radiotherapy.

van Rhijn BW, Smit M, van Geenen D, Wijnmaalen A, Kirkels WJ, van der Kwast TH, Kuenen-Boumeester V, Zwarthoff EC. van Rhijn BW, et al. Among authors: van geenen d, van der kwast th. Eur Urol. 2003 Apr;43(4):369-73. doi: 10.1016/s0302-2838(03)00059-9. Eur Urol. 2003. PMID: 12667717

9

Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome.

van Rhijn BW, Vis AN, van der Kwast TH, Kirkels WJ, Radvanyi F, Ooms EC, Chopin DK, Boevé ER, Jöbsis AC, Zwarthoff EC. van Rhijn BW, et al. Among authors: van der kwast th. J Clin Oncol. 2003 May 15;21(10):1912-21. doi: 10.1200/JCO.2003.05.073. J Clin Oncol. 2003. PMID: 12743143

10

FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma.

van Rhijn BW, van der Kwast TH, Vis AN, Kirkels WJ, Boevé ER, Jöbsis AC, Zwarthoff EC. van Rhijn BW, et al. Among authors: van der kwast th. Cancer Res. 2004 Mar 15;64(6):1911-4. doi: 10.1158/0008-5472.can-03-2421. Cancer Res. 2004. PMID: 15026322 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

273 results

Search Page

Filters